Publications

Google Scholar Profile

• Ononogbu, O., Akindele, O., Yazdanfard, S. et al. Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study. Support Care Cancer 32, 407 (2024). doi: 10.1007/s00520-024-08619-8.
• Rahimi S., Ononogbu O., Mohan A., Moussa D., Abughosh S., Trivedi M.V. Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. (2023) International Journal of Clinical Pharmacy, 45 (6) , pp. 1396-1404.doi: 10.1007/s11096-023-01609-6
• Rahimi S, Ononogbu O, Mohan A, Moussa D, Abughosh S, Trivedi M. Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status. Res Sq. 2022 Dec 22:rs.3.rs-2379786. doi: 10.21203/rs.3.rs-2379786/v1.
• Apostolidou E, Lachowiez C, Juneja H, Qiao W, Ononogbu O, Miller-Chism C, Udden M, Ma H, Mims M. Clinical outcomes of patients with newly diagnosed acute lymphoblastic leukemia in a county hospital system. Clinical Lymphoma, Myeloma and Leukemia. 2021 Nov;21(11):e895-e902. doi: 10.1016/j.clml.2021.06.022.
• Nguyen T, Ononogbu O, Egwim O, Saffari F, Ferrer J. Reducing chemotherapy administration time on an inpatient oncology unit. J Oncol Pharm Pract. 2021 Dec;27(8):1878-1882. doi: 10.1177/1078155220971737.
• Wiele A, Nguyen T, Ononogbu O. Reducing the wait time to initiate inpatient chemotherapy at Lyndon B. Johnson Hospital (Abstract). Journal of Clinical Oncology.2020 38:29_suppl, 210-210.
• Adigun M, Adesoye A, Ayoola A, Lteif L, Amaechi O. Review of Nonneurogenic Overactive Bladder, Continuing Education. US Pharmacist. Aug 2014.

Abstracts and Poster Presentations

• Johnson C, Adigwe A, Ekezie N, Fatima B, Houk K, Patel T, Shimko R, Ononogbu O, Abughosh S, Trivedi M (Jan 2024). Interventions to Improve Adherence to Oral Endocrine Therapy for Prevention or Treatment of Breast Cancer in African American Women of Low Socioeconomic Status. Poster Presentation at San Antonio Breast Cancer Symposium. San Antonio, TX.
• Akindele O, Ononogbu O (May 2022). Immunomodulator Medication Adherence in Multiple Myeloma Patients at a safety net health system. Platform Presentation at ALCALDE Meeting. Houston, TX.
• Idris Y, Lachowiez C, Trivedi M, Ononogbu O (December 2021). The Addition of Purine Analogs (Clofarabine, Cladribine, Fludarabine) to High Dose Cytarabine and Idarubicin Induction Therapy for Newly Diagnosed AML Patients: A Systematic Review. Poster Presentation at ASHP Midyear Pharmacy Conference. Virtual.
• Rahimi S, Ononogbu O, Mohan A, Moussa D, Abughosh S, Trivedi M (December 2021). Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. 2021 San Antonio Breast Cancer Symposium.
• Ononogbu O, Sulaica E, Trivedi M, Garey K (October 2021). Impact of the microbiome on chemotherapy toxicities in subjects receiving 5-fluorouracil and oxaliplatin: a systematic review. Poster Presentation at ACCP Annual Meeting. Virtual.
• Nguyen T, Ononogbu, O. (July 2018). Reducing chemotherapy administration time on an inpatient oncology unit. Presentation at ALCALDE Meeting. Webinar.
• Sirisaegtaksin, A., Ononogbu, O. (December 2017). Assessment of hypersensitivity reactions with rituximab used at a quaternary medical center. Presentation at Midyear Conference. Orlando, Florida.
• Amaechi, O., Adigun, M. (December 2013). Impact of a pharmacist-driven medication reconciliation program at a tertiary teaching institution. Presentation at ASHP Midyear Conference. Orlando, Florida.
• Amaechi, O., Lopez, T., Anosike, P., Ha, H. (December 2012). Evaluation of the Readability of Discharge Warfarin Information. Presentation at ASHP Midyear Conference. Las Vegas, Nevada.
• Amaechi, O., Ha, H., Anosike, P., (July 2012). Evaluation of the Readability of Consumer Medication Information. Presentation at the SNPhA/NPhA National Conference. Las Vegas, Nevada
• Amaechi, O., Lee, I.C., Copenhaver, M. (June 2008). A Brief Behavioral Intervention to Enhance Medication Adherence Among HIV-infected Injection Drug Users. Presentation at the College on Problems of Drug Dependence (CPDD) annual conference. San Juan, Puerto Rico.

Awards & Honors

• Diversity Equity and Inclusion Award (National), Hematology/Oncology Pharmacy Association, 2024-2025
• Patient Advocate Award, American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network, 2022
• Clinical Safety & Effectiveness Course, University of Texas MD Anderson Cancer Center, 2020
• Biomedical Informatics Certificate, UTHealth Houston, 2018
• Preceptor of the Year, Baylor St. Luke’s Medical Center, 2018
• Co-Founder, Pharmacy Initiative Leaders (PILs), 2016 - present
• Hematology Oncology Pharmacy Association, 2018 - present
• American Society of Health-System Pharmacists, 2013 - present
• Phi Lambda Sigma Pharmacy Leadership Society, 2011 - present